Helius Medical Technologies’ New Subsidiary: Revelation Neuro, Inc.
Helius Medical Technologies, the neurotech company known for its work on balance and gait deficits, has recently made some exciting announcements. They’ve established a new wholly-owned private subsidiary called Revelation Neuro, Inc.
What’s the Big Deal with Revelation Neuro?
Well, Revelation Neuro is all about advancing the development of non-implantable AI-powered BCI (Brain-Computer Interface) technology. Helius, with its existing IP portfolio and extensive data warehouse, provides a solid foundation for the AI algorithm development at Revelation Neuro.
But, What Does That Mean for Me?
For you and me, this means potential advancements in the field of neurotechnology could lead to new and improved ways to help people with balance and gait issues. Imagine a non-invasive BCI that could help improve your grandma’s mobility, or even assist individuals with spinal cord injuries to walk again.
And What About the World?
The implications of this new technology could be vast. Imagine a world where individuals with mobility issues could live more independently, or where people with neurological conditions could communicate more effectively. Revelation Neuro’s work could revolutionize the way we approach healthcare and assistive technologies.
Upcoming Presentation at the ROTH Conference
Helius will be presenting at the 37th Annual ROTH Conference on March 17, 2025, at 12:00 PM PT. This is an opportunity for investors and industry experts to learn more about the progress and potential of Revelation Neuro.
Stay Tuned
As this story develops, we’ll be sure to keep you updated on any exciting advancements from Revelation Neuro. In the meantime, let’s send some positive thoughts and well-wishes to the team as they continue their groundbreaking work in the world of neurotechnology.
- Helius establishes Revelation Neuro, Inc.
- Focused on non-implantable AI-powered BCI technology.
- Potential for significant advancements in mobility and communication.
- Presentation at 37th Annual ROTH Conference on March 17, 2025.
So there you have it, folks! A new subsidiary with the potential to change the game in neurotechnology. Stay curious and keep an eye on Revelation Neuro!
Conclusion
In the world of neurotechnology, Helius Medical Technologies’ new subsidiary, Revelation Neuro, is making waves. With a focus on non-implantable AI-powered BCI technology, this innovative company could revolutionize the way we approach mobility issues and neurological conditions. As they present at the ROTH Conference on March 17, 2025, we’ll be keeping a close eye on their progress and sending positive thoughts their way. Stay curious, my friends!
